긴코 바이오웍스(DNA)는 NYSE에 상장된 Healthcare · Biotechnology 기업입니다. 현재가 $7.72 (-1.53%), 시가총액 $0.53B, 52주 최저~최고 $5.48 ~ $16.14.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data
긴코 바이오웍스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.
긴코 바이오웍스의 현재 주가는 $7.72 (-1.53%)입니다. BlackAll Trade에서 실시간 시세와 차트를 확인할 수 있습니다.
긴코 바이오웍스의 시가총액은 약 $0.53B입니다.
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The co